In addition, CML exposure to imatinib was reported by several groups to induce chemoresistance, which is mediated by stromal cells via secreted factors such as IL-6 and IL-8 [28, 67, 68]. This evidence concerns the gene CXCL8 and chronic myelogenous leukemia, BCR-ABL1 positive.